Get startedLog in
    Picture of Annexin Pharmaceuticals AB (publ) logo

    ANNX — Annexin Pharmaceuticals AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Annexin Resolves Rights Issue Of About SEK 20 Mln

    Picture of Annexin Pharmaceuticals AB (publ) logoAnnexin Pharmaceuticals AB (publ)
    04/06/2026 07:07
    BRIEF-Annexin Resolves Rights Issue Of About SEK 20 Mln
    June 4(Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST:
    • SAID ON WEDNESDAY CO RESOLVES RIGHTS ISSUE OF ABOUT SEK 20 MLN
    • SUBSCRIPTION PRICE AMOUNTS TO SEK 12 PER NEW SHARE
    • IF OVERSUBSCRIBED, BOD MAY RESOLVE TO INCREASE TOTAL ISSUE AMOUNT BY UP TO ABOUT SEK 5 MLN THROUGH OVERALLOTMENT OPTION
            
     Source text for Workspace: nMFN65PpHl
     Further company coverage: ANNX.ST 

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Annexin Pharmaceuticals AB (publ)

    See all news